US FDA News: Statement on the agency’s efforts to protect patients through postmarket drug safety surveillance practices

Today, the FDA is issuing an update on efforts to protect patients through postmarket drug safety surveillance practices
Read more: Statement on the agency’s efforts to protect patients through postmarket drug safety surveillance practices